RNADerm Therapeutics, Inc. — Form D
RNADerm Therapeutics, Inc. of BERKELEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-15. The offering totals $14.8M, of which $750K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-03-15
- Form: D
- Accession: 0001770512-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.8M
- Amount sold: $750K
- Remaining: $14.0M
- Investors: 3
- Date of first sale: 2019-02-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-334973
Issuer
- Name: RNADerm Therapeutics, Inc.
- CIK: 0001770512
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 2600 TENTH STREET, #435, BERKELEY, CA, 94710
- Phone: 857-222-4653
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Mark de Souza | Director | Hingham, MA |
| Aaron K Sato | Director | Berkeley, CA |
| Mark de Souza | Executive Officer | Hingham, MA |
| Aaron K Sato | Executive Officer | Berkeley, CA |
More